(-)-Epigallocatechin-3-O-gallate (EGCG) reverses caffeine-induced anxiogenic-like effects

被引:30
作者
Park, Kwang-Soon
Oh, Ju Hoon
Yoo, Hwan-Soo
Lee, Yong-Moon
Lee, Myung-Koo
Hong, Jin Tae
Oh, Ki-Wan [1 ]
机构
[1] Chungbuk Natl Univ, Coll Pharm, Cheongju 361763, South Korea
关键词
Epigallocatechin-3-O-gallate (EGCG); Caffeine; Anxiogenic; Electroencephalogram (EEG); Fast/slow waves (FW/SW) ratios; ALPHA-OSCILLATIONS; BRAIN OSCILLATIONS; ANXIETY; GALLATE; MICE;
D O I
10.1016/j.neulet.2010.06.072
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This study was designed to determine whether (-)-epigallocatethin-3-O-gallate (EGCG) could reverse caffeine-induced anxiogenic-like effects in animals. In mice, EGCG antagonized the caffeine-induced reduction in both the open arm entry number and time-spent in open arm on elevated plus-maze. In addition, EGCG also antagonized the caffeine-induced reduction in both the central zone distance and central zone time-spent on an open field apparatus, respectively. Electroencephalogram (EEG) was recorded from the rat anterior cerebral cortex. Caffeine increased the power density-ratios of fast (FW: 8.00-20.00 Hz) and slow (SW: 0.75-8.00 Hz) frequency spectrum bands in these EEG recordings. However, EGCG reduced the caffeine-induced increase of FW/SW ratios. Thus, EGCG reverses caffeine-induced anxiogenic-like effects. We also provide additional evidence that the EEG FW/SW (or SW/FW) ratios can be a useful tool for the prediction of anxiogenic and/or anxiolytic effects in an animal model. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:131 / 134
页数:4
相关论文
共 50 条
[11]   ANXIOGENIC-LIKE EFFECTS INDUCED BY STIMULATION OF DOPAMINE-RECEPTORS [J].
SIMON, P ;
PANISSAUD, C ;
COSTENTIN, J .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1993, 45 (03) :685-690
[12]   Epigallocatechin-3-O-gallate (EGCG) protects the insulin sensitivity in rat L6 muscle cells exposed to dexamethasone condition [J].
Zhang, Z. F. ;
Li, Q. ;
Liang, J. ;
Dai, X. Q. ;
Ding, Y. ;
Wang, J. B. ;
Li, Y. .
PHYTOMEDICINE, 2010, 17 (01) :14-18
[13]   Antiviral Mechanism of Action of Epigallocatechin-3-O-gallate and Its Fatty Acid Esters [J].
Kaihatsu, Kunihiro ;
Yamabe, Miyuki ;
Ebara, Yasuhito .
MOLECULES, 2018, 23 (10)
[14]   Development of High-Order Functions Using (-)-Epigallocatechin-3-O-gallate in Water [J].
Ishizu, Takashi .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2020, 68 (12) :1143-1154
[15]   Differentiation-associated alteration in sensitivity to apoptosis induced by (-)-epigallocatechin-3-O-gallate in HL-60 cells [J].
Okada, Norihisa ;
Tanabe, Hiroki ;
Tazoe, Hideaki ;
Ishigami, Yoko ;
Fukutomi, Ryuuta ;
Yasui, Kensuke ;
Isemura, Mamoru .
BIOMEDICAL RESEARCH-TOKYO, 2009, 30 (04) :201-206
[16]   (-)-Epigallocatechin-3-O-Gallate Augments Pentobarbital-Induced Sleeping Behaviors Through Cl- Channel Activation [J].
Park, Kwang-Soon ;
Han, Jin-Yi ;
Moon, Dong-Cheul ;
Hong, Jin Tae ;
Oh, Ki-Wan .
JOURNAL OF MEDICINAL FOOD, 2011, 14 (11) :1456-1462
[17]   The effects of nicotine on nitric oxide induced anxiogenic-like behaviors in the dorsal hippocampus [J].
Piri, Morteza ;
Nasehi, Mohammad ;
Shahab, Zahra ;
Zarrindast, Mohammad Reza .
NEUROSCIENCE LETTERS, 2012, 528 (02) :93-98
[18]   Protective effects of epigallocatechin gallate (EGCG) on streptozotocin-induced diabetic nephropathy in mice [J].
Yoon, Sang Ni ;
Maeng, Young Hee ;
Hong, Ran ;
Lee, Byung Rai ;
Kim, Chong Gue ;
Kim, Hyun Lee ;
Chung, Jong Hoon ;
Shin, Byung Chul .
ACTA HISTOCHEMICA, 2014, 116 (08) :1210-1215
[19]   Suppressive effect of epigallocatechin-3-O-gallate on endoglin molecular regulation in myocardial fibrosis in vitro and in vivo [J].
Lin, Chiu-Mei ;
Chang, Hang ;
Wang, Bao-Wei ;
Shyu, Kou-Gi .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2016, 20 (11) :2045-2055
[20]   An investigation of the mechanisms responsible for acute fluoxetine-induced anxiogenic-like effects in mice [J].
Belzung, C ;
Le Guisquet, AM ;
Barreau, S ;
Calatayud, F .
BEHAVIOURAL PHARMACOLOGY, 2001, 12 (03) :151-162